Fingerprint
Dive into the research topics of 'Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Grzegorz S. Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas S. Larsen, Krish Patel, Ulrich Jäger, Robert F. Manges, Lorenz Trümper, Hele Everaus, Nagesh Kalakonda, Peter Brown, Judit Meszaros Jørgensen, David Cunningham, Justine Dell’Aringa, Brian Fox, Neus Domper Rubio, Nurgul Kilavuz, Marie Laure Casadebaig, Oliver Manzke, Javier Munoz
Research output: Contribution to journal › Article › peer-review